Pneumococcal 15-valent Conjugate Vaccine (Merck Sharp & Dohme)

N/A

Report date: 2026/05/24 20:00:34

Base Information

Drug NamePneumococcal 15-valent Conjugate Vaccine (Merck Sharp & Dohme)
Drug Alias Name15价肺炎球菌结合疫苗（默沙东）V114 aluminum-adjuvantedPneumococcal vaccine conjugate 15 valent15-valent pneumococcal conjugate vaccineVaxneuvance +[11] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOtitis MediaChickenpoxPneumonia, Pneumococcal +[4] 
Global Approved IndicationsPneumococcal Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/07/16
Country/TerritoryCzechiaBelgiumCanada +[37] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcMerck Sharp & Dohme CorpMerck Sharp & Dohme Bv +[5] 
Inactive CompaniesN/A
Active IndicationsOtitis MediaChickenpoxPneumococcal Infections
Inactive IndicationsPneumonia, Pneumococcal

Other Information

ATC CodeN/A
Related LinksN/A